CRMD

Cormedix

7.28

0.000.00%

After Hours: 7.30 +0.02 +0.27%19:49 10/07 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE7.27/7.28

TODAY RANGE7.18-7.31

VOL833.08K

MARKET CAP567.43M

52 WEEK RANGE6.13-13.02

AVG VOL (3M)1.06M

% TURNOVER0.89%

TURNOVER--

P/E (TTM)3.417

% RANGE1.79%

EPS(TTM)2.131

P/E(FORWARD)14.71

P/B1.227

BVPS5.93

DIVIDEND--

P/S1.851

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP524.26M

SHARES OUTSTANDING77.94M

NEXT EARNINGS11/10-11/16

FREE FLOAT72.01M

LOT SIZE1

EX-DATE03/26/2019

News

Press Releases

Financial Reports

Profile

NASDAQ·09/23 21:15
Oppenheimer Initiates Coverage of CorMedix at Outperform
Dow Jones·09/23 10:42
CorMedix Price Target Announced at $15.00/Share by Oppenheimer
NASDAQ·09/07 13:55
Wall Street Analysts Think CorMedix (CRMD) Could Surge 67.73%: Read This Before Placing a Bet
NASDAQ·08/31 16:00
CorMedix (CRMD) Upgraded to Buy: Here's Why
TipRanks·08/21 00:22
Cormedix Inc. Earnings Call Signals Strong Growth
Seeking Alpha·08/18 09:23
CorMedix: Durable Commercial Base, But 2027 Is The Real Test
Dow Jones·08/14 15:36
CorMedix Is Maintained at Outperform by RBC Capital
TipRanks·08/14 12:36
RBC Capital Sticks to Their Buy Rating for Cormedix (CRMD)
TipRanks·08/14 10:25
Buy Rating Reiterated on CRMD as Analyst Sees Undervalued Post-2027 Growth and Maintains $13 Price Target
TipRanks·08/13 17:30
Analysts Are Bullish on Top Healthcare Stocks: Parabilis Medicines, Inc. (PBLS), Cormedix (CRMD)
Seeking Alpha·08/13 17:14
CorMedix shares jump 15% after Q2 earnings beat
NASDAQ·08/13 12:45
CorMedix (CRMD) Q2 Earnings and Revenues Top Estimates
Dow Jones·08/13 11:45
*CorMedix Raises FY Adj EBITDA Guidance to $125 M to $140 M >CRMD
Dow Jones·08/13 11:45
*CorMedix FY Cash OpEx Guidance Is Narrowed to $145 M to $155 M >CRMD
Dow Jones·08/13 11:44
*CorMedix Backs FY26 Rev $325M-$345M >CRMD

Same Industry

Name/Symbol

Change%

Price

CRMD

McKesson

MCK

-0.31%

866.64

Biogen Inc

BIIB

-1.62%

215.50

Amgen Inc

AMGN

+1.55%

385.65

Shire

SHPG

0.00%

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+7.67%

0.1249

Lilly Eli & Co

LLY

+1.04%

Celgene

CELG

0.00%

108.24

Therapeuticsmd Inc

TXMD

0.00%

2.030

Johnson & Johnson

JNJ

-0.09%

269.99

Abbvie Inc

ABBV

+0.35%

266.69

Zoetis Inc

ZTS

-0.74%

70.87

Gilead Sciences Inc

GILD

-0.52%

150.11

NVO

Bristol-Myers Squibb Co

BMY

+0.35%

63.06

Pfizer

PFE

-2.10%

27.53

Alexion Pharms

ALXN

+1.70%

182.50

Sanofi FR

GCVRZ

0.00%

0.8711

Sanofi FR

SNY

+0.42%

41.11

Novartis

NVS

-0.39%

140.37

Dr Reddys Labs

RDY

0.00%

12.19

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.